Accelerating tuberculosis vaccine development.

The existing TB vaccine can reduce the risk of infection in children, but does not protect people over the many years that they are at risk for the disease. In February, the foundation announced a grant of $82.9 million to the Aeras Global TB Vaccine Foundation to support human trials of promising TB vaccines and early research on the next generation of vaccines. In 2004, Aeras began trials of two promising new vaccine candidates.